@article{ajmcr2020852,
author={{MD, Evan Botti and MD, Michelle Likhtshteyn and MD, Ghulam Ilyas and Marzouk, Evan and MD, Kakin R. Iong},
title={Drug Induced Liver Injury due to Hydralazine: A Case Report and Review of Literature},
journal={American Journal of Medical Case Reports},
volume={8},
number={5},
pages={115--118},
year={2020},
url={http://pubs.sciepub.com/ajmcr/8/5/2},
issn={2374-216X},
abstract={Drug Induced Liver Injury (DILI)accounts for around 11% of all Acute Liver Failure (ALF)cases and are usually associated with over the counter supplements [1]. Hepatotoxicity due to Hydralazine is not commonly reported [2]. Often times DILI may have variable presentations and latency times, making diagnosis difficult. Here we present a 70-year-oldfemale with multiple medical problems who presented to the hospital with jaundice and abdominal pain and concluded to have hydralazine induced liver injury.},
doi={10.12691/ajmcr-8-5-2}
publisher={Science and Education Publishing}
}